Chelsea Therapeutics to Present at 11th Annual Needham Healthcare Conference
02. April 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., April 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 11th Annual Needham Healthcare Conference at 10:00 AM ET on...
Chelsea Therapeutics Receives Complete Response Letter from Food and Drug Administration for Northera(TM) (droxidopa) Capsules
28. März 2012 18:39 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 28, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete...
Chelsea Therapeutics to Present at Roth 24th Annual OC Growth Stock Conference
12. März 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 12, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Keith Schmidt, VP Marketing and Sales, is scheduled to present at the Roth 24th...
Chelsea Therapeutics to Present at Cowen and Company 32nd Annual Healthcare Conference
07. März 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 7, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Cowen and...
Chelsea Therapeutics Reports Fourth Quarter and Full Year 2011 Results
06. März 2012 16:05 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 6, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2011 and will host a...
Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
02. März 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 2, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it plans to release fourth quarter and full year 2011 results after the market...
FDA Advisory Panel Recommends Approval of Chelsea's NORTHER(TM) (droxidopa) for the Treatment of Symptomatic Neurogenic OH
23. Februar 2012 17:05 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
Chelsea Therapeutics to Discuss NORTHERA(TM) (droxidopa) NDA for the Treatment of Symptomatic Neurogenic OH at FDA Advisory Committee Meeting on February 23
21. Februar 2012 08:14 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) will meet with the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs...
Chelsea Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
16. Februar 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced Dr. Simon Pedder, president and CEO, is scheduled to present at the Leerink Swann...
Chelsea Therapeutics CEO to Review NORTHERA(TM) NDA and Provide an Update on Upcoming Advisory Committee Meeting During Presentation at BIO CEO
13. Februar 2012 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that during a presentation at the 14th Annual BIO CEO and Investor Conference...